MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    Depression in Patients with Parkinson’s disease among Tomsk population

    M. Nikitina, N. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: To identify clinical predictors of depression in Tomsk PwPD. Background: Depression is often an under-recognized feature of Parkinson's disease (PD). It is important to…
  • MDS Virtual Congress 2021

    Effects of white matter hyperintensities, neuropsychiatric symptoms, and cognition on activities of daily living: Differences between Dementia with Lewy Bodies and Alzheimer’s disease

    S. Mirza, U. Saeed, J. Ramirez, N. Herrmann, S. Black, M. Masellis (Toronto, Canada)

    Objective: To investigate if White matter hyperintensities (WMHs), neuropsychiatric symptoms and cognitive performance associate with, and/or predict activities of daily living (ADLs) differently in Alzheimer’s…
  • MDS Virtual Congress 2021

    Initial longitudinal analyses of objectively assessed cognitive functional abilities in a cohort with Parkinson’s disease

    S. Holden, A. Fought, K. Olson, N. Lopez-Esquibel, T. Carlisle, L. Medina (Aurora, USA)

    Objective: Detect the earliest changes in cognitively demanding activities of daily living in Parkinson's disease (PD) and determine their relationship with changes in global cognition…
  • MDS Virtual Congress 2021

    The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

    R. Schade, E. Bayram (La Jolla, USA)

    Objective: This study examines whether severity and the functional impact of cognitive decline in Parkinson’s disease mild cognitive impairment (PD MCI) participants differ between those…
  • MDS Virtual Congress 2021

    Cognition-related functional topographies in Parkinson’s disease: Localized loss of the ventral default mode network

    K. Schindlbeck, A. Vo, P. Mattis, K. Villringer, F. Marzinzik, J. Fiebach, D. Eidelberg (Manhasset, USA)

    Objective: We sought to determine whether functional network abnormalities seen in patients with Parkinson’s disease (PD) and cognitive decline reflect the loss of the default…
  • MDS Virtual Congress 2021

    Combined effects of GBA mutations and STN-DBS negatively impact cognition in Parkinson’s disease

    G. Pal, G. Mangone, E. Hill, V. Lythe, D. Ehrlich, R. Saunders-Pullman, V. Shanker, S. Bressman, R. Alcalay, P. Garcia, K. Marder, J. Aasly, M. Mouradian, B. Ouyang, Y. Liu, S. Ruehl, M. Rosenbaum, S. Anderson, B. Bernard, D. Hall, S. Sani, L. Verhagen, R. Debie, T. Foltynie, J. Corvol, C. Goetz (New Brunswick, USA)

    Objective: To compare the rate of change in cognition between glucocerebrosidase (GBA) mutation carriers and non-carriers with and without subthalamic nucleus deep brain stimulation (STN-DBS)…
  • MDS Virtual Congress 2021

    Morbidity and mortality from neurodegenerative patients hospitalized with COVID-19 in the Chicagoland area

    R. Patel, G. Stebbins, B. Barton (Chicago, USA)

    Objective: To assess morbidity and mortality of acute COVID-19 infection in hospitalized patients with neurodegenerative diseases and compare with age-matched controls. Background: Outcomes from COVID-19…
  • MDS Virtual Congress 2021

    Central and Peripheral neurological manifestations of COVID-19 in a cohort of patients with Parkinson’s disease.

    A. Vaish, B. Tyson, S. Ray (Redmond, USA)

    Objective: To describe central and peripheral neurological manifestations in patients with COVID-19 and Parkinson’s disease. Background: COVID-19 is associated with central and peripheral neurological manifestations.…
  • MDS Virtual Congress 2021

    RELATION BETWEEN COGNITIVE INHIBITORY CONTROL AND ANTICIPATORY POSTURAL ADJUSTMENT DURING A CONFLICTUAL STEP INITIATION TASK IN PARKINSON’S DISEASE INDIVIDUALS.

    SM. Hondo, CN. de Oliveira, LS. de Oliveira, RC. Treza, MJ. Carvalho, AC. de Lima-Pardini, DB. Coelho (Sp, Brazil)

    Objective: Verify the association of inhibitory control on anticipatory postural adjustments (APA) during a conflictual step initiation task in individuals with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2021

    Facial emotion recognition and social behavioral problems in de novo parkinson’s disease patients

    A. Slomp, S. Vander Zee, J. Boertien, M. Gerritsen, T. van Laar, J. Spikman (Groningen, Netherlands)

    Objective: To examine facial emotion recognition (FER) as crucial component of social cognition and its relationship with social-behavioral problems in de novo drug-naïve Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley